Current controversies and challenges in Brugada syndrome

Afik D. Snir, Hariharan Raju

Research output: Contribution to journalReview article

Abstract

More than three decades since its initial description in 1993, Brugada syndrome remains engulfed in controversy. This review aims to shed light on the main challenges surrounding the diagnostic pathway and criteria, risk stratification of asymptomatic patients, pharmacological and interventional risk modification strategies as well as our current pathophysiological understanding of the disease.

Original languageEnglish
Pages (from-to)169-174
Number of pages6
JournalEuropean Cardiology
Volume14
Issue number3
DOIs
Publication statusPublished - Dec 2019

Bibliographical note

Copyright the Publisher 2019. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

Keywords

  • Brugada syndrome
  • ICD
  • quinidine
  • radiofrequency ablation

Fingerprint Dive into the research topics of 'Current controversies and challenges in Brugada syndrome'. Together they form a unique fingerprint.

  • Cite this